Fair Value Measurements - Schedule of Fair Value of Convertible Debt and Earnout Shares Liability (Details) - USD ($) $ in Thousands |
9 Months Ended | |
|---|---|---|
Sep. 30, 2024 |
Sep. 30, 2023 |
|
| Convertible Debt | ||
| Fair Value Of The Earnout Shares And Private Placement Warrants [Roll Forward] | ||
| Beginning fair value | $ 16,052 | $ 0 |
| Additions during the period | 87,046 | 71,438 |
| Payments in cash and common stock during the period | (97,091) | 0 |
| Change in fair value during the period | 36,633 | 1,339 |
| Ending fair value | 42,640 | 72,777 |
| Earnout Shares Liability | ||
| Fair Value Of The Earnout Shares And Private Placement Warrants [Roll Forward] | ||
| Beginning fair value | 41 | $ 3,013 |
| Change in fair value during the period | (41) | |
| Ending fair value | $ 0 | |
| X | ||||||||||
- Definition Fair Value Of The Earnout Shares And Private Placement Warrants No definition available.
|
| X | ||||||||||
- Definition Amount of issuances of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of increase (decrease) of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of settlements of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|